Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 10 | 5 | 2,922 | 398 | 0 |
| Gross Profit | 10 | 5 | 2,922 | 398 | N/A |
| Operating Expenses | 4,822 | 34,272 | 38,027 | 77,947 | 80,361 |
| Operating Income | -4,812 | -34,267 | -35,105 | -77,549 | -80,361 |
| Interest Expense | 0 | 1,921 | 3,154 | 1,189 | 0 |
| Other Income | 133 | 1,048 | 529 | -13 | 385 |
| Pre-tax Income | -4,679 | -35,140 | -37,730 | -78,751 | -79,976 |
| Net Income Continuous | -4,679 | -35,140 | -37,730 | -78,751 | -79,976 |
| Net Income | $-4,679 | $-35,140 | $-37,730 | $-78,751 | $-79,976 |
| EPS Basic Total Ops | -2.92 | -21.97 | -26.10 | -55.47 | -56.97 |
| EPS Basic Continuous Ops | -2.92 | -21.96 | -26.07 | -55.07 | -57.20 |
| EPS Diluted Total Ops | -2.92 | -21.97 | -26.10 | -55.47 | -56.97 |
| EPS Diluted Continuous Ops | -2.92 | -21.96 | -26.07 | -55.07 | -57.20 |
| EPS Diluted Before Non-Recurring Items | -2.92 | -19.00 | -25.49 | -55.47 | -56.97 |
| EBITDA(a) | $-4,810 | $-30,613 | $-31,365 | $-74,569 | $-79,233 |